![Digistain gains clinical data to support rapid breast cancer assessment method](jpg/newseventsimage_1706183049775_featurenews2012_x1.jpg)
![shadow](png/image_shadow_sidebar.png)
Digital diagnosis
Digistain gains clinical data to support rapid breast cancer assessment method
Digistain, a company with its roots at Imperial, has proven the worth of its breast cancer assessment method in a significant clinical trial.